Skip to content

MBX Biosciences, Inc. MBX Free cash flow yield

Free cash flow yield at other companies

Eli Lilly logo
Eli LillyLLY
1.4%+0.9pp
Amgen logo
AmgenAMGN
4.5%-2.0pp
Amylyx Pharmaceuticals, Inc. logo
Amylyx Pharmaceuticals, Inc.AMLX
-9.3%-4.3pp
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-3.1%
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
-16.6%-0.6pp
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
-11%+4.2pp

Other financials

Income statement

See full
Operating income-$27.3M-2.8%
Net income-$23.5M+1.5%
EPS (diluted)-$0.50+29.6%

Balance sheet

See full
Cash & equivalents$45.2M+51.2%
Total debt$555.0K+327%
Total equity$437.8M+85.9%
Total assets$452.7M+84.1%

Cash flow

See full
Operating cash flow-$20.2M+10.9%
CapEx$437.0K+1,357%
Free cash flow-$20.6M+9.1%

Valuation

See full
Market cap$2.3B+475%

Returns & leverage

See full
Return on equity-25.7%
Debt / equity0.0×
Current ratio30.8×+7.5×

Where this comes from

Calculated from MBX Biosciences, Inc.’s reported figures.

Based on trailing twelve months.

The official record: MBX Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about MBX Biosciences, Inc.'s free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MBX Biosciences, Inc.'s free cash flow yield?
MBX Biosciences, Inc. (MBX) reported free cash flow yield of -5.6% in Q1 2026.
How has MBX Biosciences, Inc.'s free cash flow yield changed year-over-year?
MBX Biosciences, Inc.'s free cash flow yield increased by 79.4% year-over-year, from -27.3% to -5.6%.
What does free cash flow yield mean?
Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.